Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.9B | 19.0B | 22.2B | 20.7B |
Cost of revenue | 8.0B | 9.0B | 10.7B | 10.0B |
Gross profit | 9.8B | 10.0B | 11.5B | 10.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.2B | 3.0B | 3.0B | 2.8B |
Operating income | 3.8B | 4.1B | 5.7B | 5.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 79M | 83M | 85M | 83M |
Other income expense | — | — | — | — |
Pretax income | 4.3B | 4.8B | 6.6B | 5.7B |
Tax provision | 1.0B | 1.1B | 1.5B | 1.2B |
Net income | 3.3B | 3.7B | 5.1B | 4.5B |
Basic EPS | — | 24.6 | 33.5 | 29.6 |
Diluted EPS | — | 24.6 | 33.5 | 29.6 |
Basic average shares | — | 151.8M | 151.7M | 151.7M |
Diluted average shares | — | 151.8M | 151.7M | 151.7M |
EBITDA | 5.4B | 5.9B | 7.8B | 6.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |